311 related articles for article (PubMed ID: 25322927)
1. Lymphocytic mitochondrial aconitase activity is reduced in Alzheimer's disease and mild cognitive impairment.
Mangialasche F; Baglioni M; Cecchetti R; Kivipelto M; Ruggiero C; Piobbico D; Kussmaul L; Monastero R; Brancorsini S; Mecocci P
J Alzheimers Dis; 2015; 44(2):649-60. PubMed ID: 25322927
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of vitamin E forms and risk of cognitive impairment in a Finnish cohort of older adults.
Mangialasche F; Solomon A; Kåreholt I; Hooshmand B; Cecchetti R; Fratiglioni L; Soininen H; Laatikainen T; Mecocci P; Kivipelto M
Exp Gerontol; 2013 Dec; 48(12):1428-35. PubMed ID: 24113154
[TBL] [Abstract][Full Text] [Related]
3. Peripheral oxidative stress biomarkers in mild cognitive impairment and Alzheimer's disease.
Torres LL; Quaglio NB; de Souza GT; Garcia RT; Dati LM; Moreira WL; Loureiro AP; de Souza-Talarico JN; Smid J; Porto CS; Bottino CM; Nitrini R; Barros SB; Camarini R; Marcourakis T
J Alzheimers Dis; 2011; 26(1):59-68. PubMed ID: 21593563
[TBL] [Abstract][Full Text] [Related]
4. Serum vitamin D in patients with mild cognitive impairment and Alzheimer's disease.
Ouma S; Suenaga M; Bölükbaşı Hatip FF; Hatip-Al-Khatib I; Tsuboi Y; Matsunaga Y
Brain Behav; 2018 Mar; 8(3):e00936. PubMed ID: 29541546
[TBL] [Abstract][Full Text] [Related]
5. Dietary pattern and antioxidants in plasma and erythrocyte in patients with mild cognitive impairment from China.
Yuan L; Liu J; Ma W; Dong L; Wang W; Che R; Xiao R
Nutrition; 2016 Feb; 32(2):193-8. PubMed ID: 26690564
[TBL] [Abstract][Full Text] [Related]
6. Plasma protein profiling of mild cognitive impairment and Alzheimer's disease across two independent cohorts.
Muenchhoff J; Poljak A; Song F; Raftery M; Brodaty H; Duncan M; McEvoy M; Attia J; Schofield PW; Sachdev PS
J Alzheimers Dis; 2015; 43(4):1355-73. PubMed ID: 25159666
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial Alterations in Peripheral Mononuclear Blood Cells from Alzheimer's Disease and Mild Cognitive Impairment Patients.
Delbarba A; Abate G; Prandelli C; Marziano M; Buizza L; Arce Varas N; Novelli A; Cuetos F; Martinez C; Lanni C; Memo M; Uberti D
Oxid Med Cell Longev; 2016; 2016():5923938. PubMed ID: 26881032
[TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid cortisol and clinical disease progression in MCI and dementia of Alzheimer's type.
Popp J; Wolfsgruber S; Heuser I; Peters O; Hüll M; Schröder J; Möller HJ; Lewczuk P; Schneider A; Jahn H; Luckhaus C; Perneczky R; Frölich L; Wagner M; Maier W; Wiltfang J; Kornhuber J; Jessen F
Neurobiol Aging; 2015 Feb; 36(2):601-7. PubMed ID: 25435336
[TBL] [Abstract][Full Text] [Related]
9. Buccal Cell Cytokeratin 14 Correlates with Multiple Blood Biomarkers of Alzheimer's Disease Risk.
Leifert WR; Nguyen T; Rembach A; Martins R; Rainey-Smith S; Masters CL; Ames D; Rowe CC; Macaulay SL; François M; Fenech MF;
J Alzheimers Dis; 2015; 48(2):443-52. PubMed ID: 26402008
[TBL] [Abstract][Full Text] [Related]
10. Increased Plasma Beta-Secretase 1 May Predict Conversion to Alzheimer's Disease Dementia in Individuals With Mild Cognitive Impairment.
Shen Y; Wang H; Sun Q; Yao H; Keegan AP; Mullan M; Wilson J; Lista S; Leyhe T; Laske C; Rujescu D; Levey A; Wallin A; Blennow K; Li R; Hampel H
Biol Psychiatry; 2018 Mar; 83(5):447-455. PubMed ID: 28359566
[TBL] [Abstract][Full Text] [Related]
11. γH2AX is increased in peripheral blood lymphocytes of Alzheimer's disease patients in the South Australian Neurodegeneration, Nutrition and DNA Damage (SAND) study of aging.
Siddiqui MS; Francois M; Hecker J; Faunt J; Fenech MF; Leifert WR
Mutat Res Genet Toxicol Environ Mutagen; 2018; 829-830():6-18. PubMed ID: 29704994
[TBL] [Abstract][Full Text] [Related]
12. Oxidative stress and APO E polymorphisms in Alzheimer's disease and in mild cognitive impairment.
Chico L; Simoncini C; Lo Gerfo A; Rocchi A; Petrozzi L; Carlesi C; Volpi L; Tognoni G; Siciliano G; Bonuccelli U
Free Radic Res; 2013 Aug; 47(8):569-76. PubMed ID: 23668794
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D Increases Aβ140 Plasma Levels and Protects Lymphocytes from Oxidative Death in Mild Cognitive Impairment Patients.
SanMartin CD; Henriquez M; Chacon C; Ponce DP; Salech F; Rogers NK; Behrens MI
Curr Alzheimer Res; 2018; 15(6):561-569. PubMed ID: 29283046
[TBL] [Abstract][Full Text] [Related]
14. Oxidative and nitrosative modifications of biliverdin reductase-A in the brain of subjects with Alzheimer's disease and amnestic mild cognitive impairment.
Barone E; Di Domenico F; Cenini G; Sultana R; Coccia R; Preziosi P; Perluigi M; Mancuso C; Butterfield DA
J Alzheimers Dis; 2011; 25(4):623-33. PubMed ID: 21483094
[TBL] [Abstract][Full Text] [Related]
15. Decreased mean platelet volume and platelet distribution width are associated with mild cognitive impairment and Alzheimer's disease.
Wang RT; Jin D; Li Y; Liang QC
J Psychiatr Res; 2013 May; 47(5):644-9. PubMed ID: 23395109
[TBL] [Abstract][Full Text] [Related]
16. Chromosomal DNA damage measured using the cytokinesis-block micronucleus cytome assay is significantly associated with cognitive impairment in South Australians.
Lee SL; Thomas P; Hecker J; Faunt J; Fenech M
Environ Mol Mutagen; 2015 Jan; 56(1):32-40. PubMed ID: 25099033
[TBL] [Abstract][Full Text] [Related]
17. Injury markers but not amyloid markers are associated with rapid progression from mild cognitive impairment to dementia in Alzheimer's disease.
van Rossum IA; Visser PJ; Knol DL; van der Flier WM; Teunissen CE; Barkhof F; Blankenstein MA; Scheltens P
J Alzheimers Dis; 2012; 29(2):319-27. PubMed ID: 22233766
[TBL] [Abstract][Full Text] [Related]
18. Prodromal metabolic phenotype in MCI cybrids: implications for Alzheimer's disease.
Silva DF; Santana I; Esteves AR; Baldeiras I; Arduino DM; Oliveira CR; Cardoso SM
Curr Alzheimer Res; 2013 Feb; 10(2):180-90. PubMed ID: 22746213
[TBL] [Abstract][Full Text] [Related]
19. Serum tumour necrosis factor-α and interleukin-6 levels in Alzheimer's disease and mild cognitive impairment.
Kim YS; Lee KJ; Kim H
Psychogeriatrics; 2017 Jul; 17(4):224-230. PubMed ID: 28130814
[TBL] [Abstract][Full Text] [Related]
20. Plasma SUMO1 Protein is Elevated in Alzheimer's Disease.
Cho SJ; Yun SM; Lee DH; Jo C; Ho Park M; Han C; Ho Koh Y
J Alzheimers Dis; 2015; 47(3):639-43. PubMed ID: 26401699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]